home / stock / knbif / knbif news

KNBIF News and Press, Kane Biotech From 11/21/23

Stock Information
Company Name: Kane Biotech
Stock Symbol: KNBIF
Market: OTC
Website: kanebiotech.com
Menu
KNBIF KNBIF Quote KNBIF Short KNBIF News KNBIF Articles KNBIF Message Board
Get KNBIF Alerts

News, Short Squeeze, Breakout and More Instantly...
KNBIF - Kane Biotech to Release Third Quarter 2023 Financial Results on November 28, 2023 - Conference Call to Follow

WINNIPEG, Manitoba, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove ...
KNBIF - Kane Biotech and ProgenaCare Global Launch Newly Rebranded revyve(TM) Antimicrobial Wound Gel at Advanced Wound Care Fall Forum

WINNIPEG, Manitoba, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) in partnership with ProgenaCare Global LLP (“ProgenaCare”) today announces the launch of the newly rebranded revyve™ A...

KNBIF - Kane Biotech to Exhibit at Symposium on Advanced Wound Care Fall Forum

WINNIPEG, Manitoba, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it will be unveiling the new brand for its coactiv+™ Antimicrobial Wound Gel product (“Wound Gel”...

KNBIF - Kane Biotech Announces Closing of Fully Subscribed Private Placement Offering and Amendments to its Credit Facility

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “ Company ”, “ Kane ” or “ Kane Biotech ”) announ...
KNBIF - Kane Biotech GAAP EPS of -$0.01, revenue of $0.66M

2023-08-29 16:48:05 ET More on Kane Biotech Kane Biotech GAAP EPS of -$0.01, revenue of $0.84M For further details see: Kane Biotech GAAP EPS of -$0.01, revenue of $0.66M

KNBIF - Kane Biotech Announces Second Quarter 2023 Financial Results

68% Increase in Product and Services Revenue; 74% Increase in Royalties Revenue WINNIPEG, Manitoba, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its second quarter 2023 financial...

KNBIF - Kane Biotech to Release Second Quarter 2023 Financial Results on Aug 29, 2023 - Conference Call to Follow

WINNIPEG, Manitoba, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove ...
KNBIF - Kane Biotech Announces Private Placement Offering and Proposed Amendments to its Credit Facility

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “ Company ”, “ Kane ” or “ Kane Biotech ”) today a...

KNBIF - Kane Biotech Engages Research Capital to Conduct Strategic Review of STEM Animal Health

WINNIPEG, Manitoba, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “ Company ”, “ Kane ” or “ Kane Biotech ”) announced today that it has engaged Research Capital Corporation as Kane’s exclusive financi...

KNBIF - Kane Biotech Announces Issuance of Restricted Share Units

WINNIPEG, Manitoba, June 23, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has issued 9,703,809 restricted share units of the Company (“RSUs”) to various directors, officers...
Previous 10 Next 10